T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer

T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer

Abstract Background Immune checkpoint inhibitors are a standard treatment for advanced lung cancer, although it remains important to identify biomarkers that can accurately predict treatment response. Immune checkpoint inhibitors enhance the antitumor T‐cell response, and interferon‐γ plays an impor...

Full description

Bibliographic Details
Main Authors: Chisato Kamimaki, Nobuaki Kobayashi, Momo Hirata, Kohei Somekawa, Nobuhiko Fukuda, Sousuke Kubo, Seigo Katakura, Shuhei Teranishi, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Masaki Yamamoto, Makoto Kudo, Hongmei Piao, Takeshi Kaneko
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Thoracic Cancer
Subjects:
immune checkpoint inhibitor
interferon‐γ
interferon‐γ‐releasing assay
lung cancer
T‐SPOT.TB
Online Access:https://doi.org/10.1111/1759-7714.13978

Internet

https://doi.org/10.1111/1759-7714.13978

Similar Items